Mapping Multiple Myeloma Advances in NYC

Dr. Oh

Listen as host and Senior Editor Kristi Rosa of OncLive interviews experts from Mount Sinai at the State of the Science Summit™ on Multiple Myeloma, including:

Sundar Jagannath, MBBS, Director of the Center of Excellence for Multiple Myeloma, and Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai

Ajai Chari, MD, Director of Clinical Research, Center of Excellence for Multiple Myeloma; Associate Director of Clinical Research, Mount Sinai Cancer Clinical Trials Office; Associate Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai

Joshua Richter, MD, Assistant Professor of Medicine (Hematology and Medical Oncology), The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Deepu Madduri, MD, Assistant Professor of Medicine (Hematology and Medical Oncology), and Urology, Icahn School of Medicine at Mount Sinai

Hearn Jay Cho, MD, PhD, Associate Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai

Samir Parekh, MBBS, Director of Translational Research, Associate Professor of Medicine (Hematology and Medical Oncology), and Oncological Sciences, Icahn School of Medicine at Mount Sinai

You’ll hear them discuss emerging treatment strategies in multiple myeloma, including headway made with CAR T-cell therapies, the role of genomics, the shift toward personalized medicine, and progress made with maintenance therapies.